Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • STATUS
    Recruiting
  • End date
    Jan 2, 2029
  • participants needed
    102
  • sponsor
    More Foundation
Updated on 19 February 2024
osteoarthritis
total knee replacement
arthritis
biomet
gait evaluation

Summary

Previous motion analysis studies have demonstrated excellent ability to distinguish subtle differences in gait between normal subjects and those suffering from arthritis. With proper techniques and analysis differences between osteoarthritis patient groups can be distinguished. Previous research has indicated that subjects who received a single-radius design total knee replacement have superior gait performance that those who received a multi-radius design total knee replacement. The DJO Global Empowr PS Knee System is a single-radius lateral pivot design. This design should achieve reproducible more natural knee function and improved patient outcomes and satisfaction. A motion analysis laboratory will be used to collect gait data from patients who are going to receive a Empowr PS knee device and also from age-matched control subjects. These data will be compared with data previously collected from patients who received Stryker Triathlon devices, Biomet Vanguard devices and age-matched healthy control subjects.

Description

Thirty subjects who are scheduled to receive an Empowr PS Total Knee Replacement device will be consented to be in the prospective component of the study. Twenty of these patients will participate in motion data collection. These patients will all be scheduled to undergo primary total knee replacement using the Empowr device. All surgeries will be performed using computer navigation. Patients will receive standardized physical therapy to insure consistency of rehab protocols and discharge from physical therapy criteria. Specifically, patients will be monitored for visit compliance, Timed Up and Go (TUG) test in seconds, AROM in degrees, and walking un-aided.

Data were previously collected preoperatively, at 6 months and 1 year post-operatively for 16 patients who received a Stryker Triathlon total knee replacement and preoperatively and 1 year post-op for 16 patients who received a Biomet Vanguard total knee replacement. Data were also previously collected for 20 age matched healthy controls subjects. Data will be collected for an additional 20 control subjects. Knee Society Score (KSS) and Knee Injury and Osteoarthritis Outcome Score (KOOS) will be collected at pre-op, 6 months, 1 year, and 2 years post-op. Gait analysis data will include kinetic, kinematic, temporal spatial, and electromyographic (EMG) data throughout the gait cycle for both research subjects and controls. Reflective markers will be placed on subject's anatomical landmarks, and ten surface EMG electrodes placed according to published standards (8). Subjects will walk at a self-selected speed down a runway embedded with force plates while 10 Eagle-4 digital infrared cameras record their movement. In addition to the level surface walking, additional data on more complex activities of daily living will be collected for potential future analysis. This would include: sit-to-stand, balance, and stair-climbing measurements also using the force plates, camera system and EMG data collection.

Details
Condition Osteoarthritis of knee, Osteoarthritis, Osteoarthritis
Age 50-100 years
Treatment Control, DJO Empowr PS Knee System, Stryker Triathlon Total Knee System, Biomet Vanguard Complete Knee System
Clinical Study IdentifierNCT04275362
SponsorMore Foundation
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Controls
At least 50 years of age
Subjects who provide signed and IRB approved informed consent for gait analysis data collection
Retrospective subjects
Subjects who had primary total knee replacement with either Stryker Triathlon Total Knee System or Biomet Vanguard Complete Knee System
Subjects at least 50 years of age at the time of the surgery
Subjects who previously provided signed and informed consent for gait analysis data collection under approval of the Sun Health Institutional Review Board
Cases that followed product labeling
Prospective subjects
Subjects who are eligible for DJO Global's Empowr total knee replacement
Subjects at least 50 years of age at the time of the surgery
Subjects who are willing to provide signed and IRB approved informed consent for gait analysis data collection
Cases that followed product labeling

Exclusion Criteria

Controls
Controls with any musculoskeletal injury or disorder
Controls that are pregnant or planning on becoming pregnant
Controls with a BMI>40
Retrospective subjects
Subjects with inflammatory arthritis or psoriatic arthritis at the time of surgery
Subjects that are pregnant or planning on becoming pregnant
Subjects with a BMI>40
Subjects who had an active infection or suspected latent infection in or about the joint at the time of surgery
Subjects whose bone stock was compromised by disease, infection or prior implantation which could not provide adequate support and/or fixation of the prosthesis
Subjects who had any mental or neuromuscular disorders which created an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complication in postoperative care
Subjects with severe instability of the knee joint secondary to the absence of collateral ligament integrity and function
Prospective subjects
Subjects with inflammatory arthritis or psoriatic arthritis at the time of surgery
Subjects that are pregnant or planning on becoming pregnant
Subjects with a BMI>40
Subjects who had an active infection or suspected latent infection in or about the joint at the time of surgery
Subjects whose bone stock was compromised by disease, infection or prior implantation which could not provide adequate support and/or fixation of the prosthesis
Subjects who had any mental or neuromuscular disorders which created an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complication in postoperative care
Subjects with severe instability of the knee joint secondary to the absence of collateral ligament integrity and function
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.